Patient-reported outcome measures (PROMs) and clinical decision-making in inflammatory rheumatic conditions: a systematic review
Clicks: 2
ID: 322427
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
2 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #31 of 46 articles by views in Rheumatology Advances in Practice
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Objectives To examine the role of patient-reported outcome measures (PROM) in clinical decision-making across three inflammatory arthritides: Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Axial Spondyloarthritis (axSpA). Methods Systematic review of four on-line medical literature databases (Medline, Embase, CINAHL, Cochrane Central) from inception to February 2025. Abstracts and full texts were independently double-assessed. Articles examining the use and influence of PROMs on RA, PsA, and axSpA clinical decision-making were included, with extracted data narratively synthesised (PROSPERO registration: CRD42024550525). Results : From 16,950 identified studies, 29 were included (n = 22 RA; n = 4 axSpA; n = 3 PsA; Study design: trials n = 15; cohort n = 10; cross-sectional n = 4). PROMs supported three aspects of healthcare: 1) treatment decision-making (n = 24); 2) clinical encounters (n = 2) and 3) self-monitoring (n = 6). Treat-to-target studies (n = 14/24, commonly RA) used PROMs to guide drug alterations. However, clinicians adhered less to PROM-based treatment protocols for complex patients or those with restricted insurance policies. PROMs improved patient communication and trust in clinicians. PROM-based self-monitoring matched standard care outcomes, but service limitations reduced its efficiency. Conclusions PROMs capture valuable patient data, and show potential to support clinical decision-making, particularly in RA patients. Current PROM implementation methods are varied. Standardisation could maximise the clinical value of PROM data that, if acted upon, could enhance patient care and outcomes. However, service and clinician barriers, combined with poor standardisation, currently risk this data being underutilised.
| Reference Key |
openalex_W7170189117
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | J.-F. Grange, James A. Prior, Jon Packham, Max Somer, Helen Parsons, Kirstie Haywood |
| Journal | Rheumatology Advances in Practice |
| Year | 2026 |
| DOI |
10.1093/rap/rkag093
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.